How AI Can Help Reduce Vaccine R&D From A Year To ‘A Matter Of Weeks’

From rapidly identifying antigenic targets to automating clinical trials, AI has an important role to play in cutting vaccine development time down to 100 days, says Melanie Saville, executive director of R&D at CEPI.

Virus AI

The Coalition for Epidemic Preparedness Innovations (CEPI) has pledged to facilitate the development of new vaccines within 100 days of a new pathogen with epidemic or pandemic potential being identified, but meeting this ambitious timeline will require significantly faster processes.

To deliver on its “100-Days Mission,” an initiative backed by G7 and G20 nations and first proposed in June 2021,...

More from Europe

More from Geography